# Tamoxifen Citrate in Patients With Breast Cancer

> **NCT00963209** · PHASE3 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 140 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** tamoxifen citrate
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00963209
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2013-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00963209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00963209, "Tamoxifen Citrate in Patients With Breast Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00963209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*